Nuala Moran

Celltech Ends Development Of CDP 571 In Crohn's Indication

Aug. 27, 2003

By Nuala Moran

Research Group Grows UK's First Embryonic Stem Cell Line

Aug. 27, 2003

By Nuala Moran

Celltech Ends Development Of CDP 571 In Crohn's Indication

Aug. 27, 2003

By Nuala Moran

Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition

Aug. 20, 2003

By Nuala Moran

Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition

Aug. 20, 2003

By Nuala Moran

LONDON - Consolidation continues in the UK as Xenova Group plc announced an agreed-to £8.48 million (US$13.5 million) all-share takeover offer for KS Biomedix plc (KSB). (BioWorld International)

Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition

Aug. 20, 2003

By Nuala Moran

Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition

Aug. 20, 2003

By Nuala Moran

LONDON - Consolidation continues in the UK as Xenova Group plc announced an agreed-to £8.48 million (US$13.5 million) all-share takeover offer for KS Biomedix plc (KSB). (BioWorld International)